Annual Revenue
$2.4B
Royalty Pharma's revenue is the ranked 1st among it's top 10 competitors. The top 10 competitors average 333.4M. Over the last four quarters, Royalty Pharma's revenue has decreased by 6.1%. Specifically, in Q2 2023's revenue was $538.2M; in Q1 2023, it was $684M; in Q4 2022, it was $565.7M; in Q3 2022, Royalty Pharma's revenue was $573.5M.